Denmark: DanCann Pharma receives first tranche of convertible loan

DanCann Pharma, a Danish medical cannabis company, is issuing loan notes to an aggregate amount of DKK18.9m (US$2.9m) and 8,190,000 warrants to Nordic Growth Opportunities 2 (NGO2) in connection with the company’s receipt of a first tranche of DKK6.6m of the total loan agreement from the investor. In June, the company entered into a financing…

You must be a HMI Subscriber to view this content.

Subscribe Now »